Skip to main content
Beta version A NHS service powered by standards. Feedbackopens in a new window will help us improve.

Drugs Patient Level Contract Monitoring

undefined logo

Information Standard Notice

Acting under delegated authority from the Secretary of State for Health, the Data Coordination Board has approved a change to an existing information standard for publication under section 250 of the Health and Social Care Act 2012.

Important: Full conformance date

You must comply with this change by the full conformance date: 1 October 2021

Standard definition

Unique identifier

DCB2212 Amd 74/2020

Name
Drugs Patient Level Contract Monitoring
Approval date
25 March 2021
Publication date
8 April 2021
Documentation
opens in a new tab
(opens in new tab)

Standard definition

Description
This is one of a set of standards introduced by NHS England, initially on a voluntary basis, to enable national consistency of the flow of cost and activity information from providers to commissioners.

About this change

Scope
NHS Services
Applies to
  • All commissioners of NHS-funded services
  • All NHS/independent providers, operating under the NHS Standard Contract
  • NHS ambulance service providers, operating under the NHS Standard Contract
Impacts upon
Implementation of this information standard impacts all health IT systems suppliers providing systems to the above providers; suppliers should work with their customers to determine necessary changes.
Link to further information
Further information

Contacts

Sponsor

Ming Tang, Managing Director of Data and Analytics, NHS England

SRO
Vicky Mathwin, Deputy Director of Information and Intelligence, Specialised Services National Support Team, NHS England
Business Lead
Martin Hart, Assistant Head of Information (Reporting), NHS England
Help Desk

england.nccis@nhs.net

Dates

Implementation Date
1 September 2021
Full Conformance Date
1 October 2021
Post Implementation Review date
30 September 2022